PAPER
Synthesis of Carbohydrate-based Chiral Crown Ethers
645
bis(2-chloroethyl)ether (2 mL) and tetrabutylammonium hydrogen
sulfate (20 mg) at r.t. The reaction was complete after about 4-5
days (TLC control). After neutralisation with 10% aq AcOH, the
product was extracted with CHCl3 (3 × 10 mL). The combined or-
ganic phases were dried (Na2SO4) and concentrated under reduced
pressure in a rotary evaporator. The residue was purified by column
chromatography (Table 4).32
1H NMR (300 MHz, CDCl3): = 7.4 6.98 (m, 10 H, C6H5), 6.06
5.88 (m, 2 H, 2 CH2CH=CH2), 5.39 5.12 (m, 4 H, 2 CH2CH=CH2),
4.88 (d, 1 H, J1,2 = 7.9 Hz, 1-H), 4.57, 4.53 (2 d, 2 H, J = 11.9 Hz,
CH2Ph), 4.49 4.22 (m, 4 H, 2 CH2CH=CH2), 4.08 (m, 1 H, 5-H),
3.89 3.57 (m, 12 H, 2-H, 4-H, 6-H, 6‘-H, 4 CH2), 3.43 (dd, 1 H, J3,4
= 3.1, J2,3 = 9.7 Hz, 3-H).
Anal. Calcd for C37H54O12 (690.8): C, 64.30; H, 7.88. Found: C,
64.16; H, 7.93.
2,3-Di-O-allyl-6-O-benzyl-1,4-O-(3,6,9,12,15-pentaoxaheptade-
can-1,17-diyl)- -D-galactopyranose (16)
Under argon phenyl galactoside 15 (500 mg, 0.724 mmol) was dis-
solved in anhyd dichloroethane (20 mL) in the presence of molecu-
lar sieve (4 Å). After cooling the mixture to 10 °C, a solution of
TMSOTf (130 L, 0.724 mmol) in anhyd CH2Cl2 (5 mL) was added
while stirring within 15 min. (argon atmosphere). Stirring was con-
tinued at 10 °C for 1 h. Subsequently, the mixture was allowed to
warm up to r.t. within 2 h. Then the reaction was terminated by the
addition of CHCl3 (15 mL), H2O (5 mL) and satd aq NaHCO3 solu-
tion (10 mL) while stirring vigorously (5 min.). The organic phase
was separated, washed with H2O, dried (Na2SO4), filtered and con-
centrated under reduced pressure. After column chromatographic
purification 16 was isolated as a syrupy product (Table 4).
1H NMR (250 MHz, CDCl3): = 7.30 7.25 (m, 5 H, C6H5), 6.02
5.79 (m, 2 H, 2 CH2CH=CH2), 5.30 5.07 (m, 4 H, 2 CH2CH=CH2),
4.57, 4.53 (2 d, 2 H, J = 11.9 Hz, CH2Ph), 4.39 4.09 (m, 4 H, 2
CH2CH=CH2), 4.23 (d, 1 H, J1,2 = 7.3 Hz, 1-H), 4.09 3.44 (m, 29
H, 2-H, 4-H, 5-H, 6-H, 6’-H, 12 CH2), 3.28 (dd, 1 H, J2,3 = 9.7, J3,4
= 3.1 Hz, 3-H).
13C NMR (62 MHz, CDCl3): = 157.5, 138.8, 129.3, 128.4, 127.8,
127.7, 122.4 (C6H5), 135.4, 134.9 (2 CH2CH=CH2), 116.7, 116.6 (2
CH2CH=CH2), 101.9 (C-1), 81.4 (C-3), 78.7, 75.2 (C-2, C-5), 73.8
(C-4), 74.0, 73.6, 72.6, 72.0, 71.2, 70.9, 68.7, (C-6, 6 CH2), 42.9
(CH2Cl).
Anal. Calcd for C29H37O7 (533.0): C, 65.34; H, 7.00. Found: C,
65.37; H, 6.99.
Phenyl 2,3-Di-O-allyl-6-O-benzyl-4-O- 2- -hydroxytri(oxyeth-
ylene)ethyl }- -D-galactopyranoside (14)
13C NMR (62 MHz, CDCl3): = 138.1, 128.4, 127.9, 127.7 (C6H5),
135.5, 135.1 (2 CH2CH=CH2), 116.4, 116.2 (2 CH2CH=CH2),
103.8 (C-1), 81.5 (C-3), 79.1, 74.8, 72.9 (C-2, C-4, C-5), 74.2, 73.9,
73.8, 72.1, 71.5, 71.4, 71.2, 71.2, 71.2, 71.1, 71.1, 71.0, 70.9, 70.8,
(14 CH2), 69.4, 68.3 (CH2, C-6).
A solution of KOH (112 mg, 2.0 mmol) in diethylene glycol (6 mL)
was poured into 13 (533 mg, 1.0 mmol) under vigorous stirring and
the mixture was heated for about 5 h at 70 °C (TLC control). After
cooling to r.t., the mixture was diluted with H2O (10 mL), neutra-
lised with 10% aq HCl, and extracted with CH2Cl2 (2 × 10 mL). The
combined organic phases were dried (Na2SO4), concentrated under
reduced pressure and compound 14 was separated from the residue
by column chromatography (Table 4).
Anal. Calcd for C31H48O11 (596.7): C, 62.38; H, 8.11. Found: C,
62.62; H, 8.11.
1H NMR (250 MHz, CDCl3): = 7.38 6.98 (m, 10 H, C6H5), 6.06
5.87 (m, 2 H, 2 CH2CH=CH2), 5.39 5.12 (m, 4 H, 2 CH2CH=CH2),
4.88 (d, 1 H, J1,2 = 7.94 Hz, 1-H), 4.57 (dd, 2 H, J = 11.91 Hz,
CH2Ph), 4.49 4.21 (m, 4 H, 2 CH2CH=CH2), 4.08 (m, 1 H, 5-H),
3.91 3.47 (m, 20 H, 2-H, 4-H, 6-H, 6’-H, 8 CH2), 3.43 (dd, 1 H, J2,3
= 9.76, J3,4 = 3.05 Hz, H-3).
13C NMR (62 MHz, CDCl3): = 157.5, 138.1, 129.3, 128.4, 127.8,
127.7, 122.4 (C6H5), 135.4, 134.9 (2 CH2CH=CH2), 116.7, 116.6 (2
CH2CH=CH2), 101.8 (C-1), 81.4 (C-3), 78.7, 75.2 (C-2, C-5), 73.9
(C-4), 73.9, 73.6, 72.5, 71.9, 70.8, 70.6, 70.5, 70.3 (10 CH2), 68.8
(C-6), 61.7 (CH2OH).
6-O-Benzyl-2,3-O-bis(diphenylphosphino)-1,4-O-(3,6,9-triox-
aundecan-1,11-diyl)- -D-glucopyranoside]Rh(COD)}BF4 (18)
To a stirred solution of 8 (0.91 g, 2.1 mmol) and pyridine (0.51 mL,
6.3 mmol) in THF (10 mL) was added dropwise chlorodiphe-
nylphosphine (0.96 g, 4.3 mmol) at 0 °C and the mixture was al-
lowed to warm up to r.t. (inert gas atmosphere). After filtration
(removal of pyridine hydrochloride), the filtrate was concentrated in
vacuum and the residue dissolved in Et2O (5 mL). The Et2O solution
was diluted with pentane (4 mL), then filtered, and concentrated.
The 6-O-benzyl-2,3-O-bis(diphenylphosphino)-1,4-O-(3,6,9-triox-
aundecan-1,11-diyl)- -D-glucopyranoside (17) obtained did not
crystallize. This was used as such in the next step. Under anaerobic
conditions a solution of 17 in THF (5 mL) was added dropwise to a
stirred solution of [Rh(COD)(acac)] (620 g, 3.0 mmol) in THF (3
mL). Subsequently, 40% aq tetrafluoroboric acid (0.25 mL) was
added to the homogenous solution and complex 18 was precipitated
with Et2O, isolated by filtration, and dried in vacuum (Table 4).
Anal. Calcd for C33H46O10 (602.5): C, 65.76; H, 7.69. Found: C,
65.58; H, 7.73.
Phenyl 2,3-Di-O-allyl-6-O-benzyl-4-O- 2- -hydroxypenta(oxy-
ethylene)ethyl }- -D-galactopyranoside (15)
31P{1H} NMR (CDCl3): = 134.5 (dd, J = 180, 25 Hz) and 138.3
(dd, J = 182, 25 Hz).
A solution of KOH (112 mg, 2.0 mmol) in tetraethylene glycol (6
mL) was poured onto 13 (533 mg, 1.0 mmol) under vigorous stir-
ring and the mixture was heated for about 5 h at 70 °C (TLC con-
trol). The mixture was worked up as described for compound 14
yielding the syrupy product 15 after column chromatographic puri-
fication (Table 4).
1H NMR (250 MHz, CDCl3): = 7.34 6.94 (m, 10 H, C6H5), 6.02
5.83 (m, 2 H, 2 CH2CH=CH2), 5.35 5.08 (m, 4 H, 2 CH2CH=CH2),
4.85 (d, 1 H, J1,2 = 7.6 Hz, 1-H), 4.57, 4.53 (2 d, 2 H, J = 11.9 Hz,
CH2Ph), 4.45 4.16 (m, 4 H, 2 CH2CH=CH2), 4.04 (m, 1 H, 5-H),
3.86 3.54 (m, 28 H, 2-H, 4-H, 6-H, 6’-H, 12 CH2), 3.39 (dd, 1 H,
Anal. Calcd for C53H62BF4O9P2Rh (1094.7): C, 58.15; H, 5.71; P,
5.66; Rh 9.40. Found: C, 54.22; H, 5.61; P, 4.80; Rh, 8.99.
6-O-Benzyl-2,3-O-bis-diphenylphosphino-1,4-O-(3,6,9,12-tet-
raoxatetradecan-1,14-diyl)- -D -glucopyranoside (19)
To a solution of 9 (1.53 g, 3.24 mmol) and pyridine (0.72 mL, 8.9
mmol) in THF (5 mL) was added dropwise a solution of chlo-
rodiphenylphosphine (1.43 g, 6.48 mmol) in THF (10 mL) at 0 °C
while stirring (inert gas atmosphere) and the mixture was allowed
to warm up to r.t. After filtration (removal of pyridine hydrochlo-
ride), the filtrate was concentrated in vacuum, the residue was treat-
ed with toluene (5 mL), filtered, and concentrated (95 % yield of
crystalline 19).
J2,3 = 9.7, J3,4 = 3.1 Hz, 3-H).
13C NMR (62 MHz, CDCl3): = 157.5, 138.1, 129.3, 128.4, 127.8,
127.7, 122.4, 116.9 (C6H5), 135.4, 134.9 (2 CH2CH=CH2), 116.6,
116.5 (2 CH2CH=CH2), 101.9 (C-1), 81.5 (C-3), 78.7, 75.2 (C-2, C-
5), 73.9 (C-4), 73.9, 73.6, 72.5, 72.4, 71.9, 70.8, 70.6, 70.5, 70.3 (10
CH2), 68.8 (C-6), 61.7 (CH2OH).
31P{1H} NMR (161.9 MHz, C6D6): = 110.9 (s) and 117.4 (s).
Synthesis 2001, No. 4, 638–646 ISSN 0039-7881 © Thieme Stuttgart · New York